Autoliv, Inc. balance sheet ALV

As of Sep 30, 2026, Autoliv, Inc. had total assets of $8.4 billion. Total assets were down 0.4% from a year earlier. Stockholders' equity was $2.5 billion. It held $197.0 million in cash and investments against $2.1 billion of total debt, net debt of $1.9 billion. The current ratio, current assets divided by current liabilities, was 1.02.

USD in millions, except ratios and per-share amounts. The percent under a figure is the change from the same quarter a year earlier.

Line
Q3 FY2026
Sep 30, 2026
Q2 FY2026
Jun 30, 2026
Q1 FY2026
Mar 31, 2026
Q4 FY2025
Dec 31, 2025
Q3 FY2025
Sep 30, 2025
Q2 FY2025
Jun 30, 2025
Q1 FY2025
Mar 31, 2025
Q4 FY2024
Dec 31, 2024
Assets
Cash
197
-12.4%
377
+59.1%
342
+6.2%
604
+83.0%
225
-45.8%
237
-41.9%
322
-43.4%
330
-33.7%
Cash and investments
197
-12.4%
377
+59.1%
342
+6.2%
604
+83.0%
225
-45.8%
237
-41.9%
322
-43.4%
330
-33.7%
Receivables
—
—
—
2,236
+12.2%
—
—
—
1,993
-9.3%
Inventory
1,020
-1.5%
945
-1.3%
947
+3.7%
992
+7.7%
1,036
+3.9%
957
+2.2%
913
-8.4%
921
-9.0%
Total current assets
3,951
+0.1%
4,009
+2.0%
3,987
+7.8%
4,101
+17.7%
3,946
+2.1%
3,929
+6.1%
3,699
-7.8%
3,483
-12.4%
Property and equipment, net
2,349
-2.2%
2,340
-2.5%
2,356
+3.1%
2,417
+7.9%
2,402
+3.7%
2,399
+9.2%
2,286
+4.3%
2,239
+2.1%
Goodwill
—
—
—
1,379
+0.8%
—
—
—
1,368
-0.7%
Total assets
8,427
-0.4%
8,497
+0.2%
8,468
+4.4%
8,644
+10.8%
8,463
+1.9%
8,476
+5.8%
8,114
-2.5%
7,804
-6.3%
Liabilities and equity
Accounts payable
1,990
+5.3%
1,982
+1.9%
1,862
+1.3%
2,007
+11.6%
1,889
+0.4%
1,945
+4.7%
1,839
-0.9%
1,799
-9.0%
Total current liabilities
3,859
-6.8%
3,897
-8.0%
3,708
-2.4%
3,923
+8.0%
4,141
+2.7%
4,235
+11.9%
3,800
+3.9%
3,633
-10.0%
Stockholders' equity
2,459
-3.5%
2,490
+0.9%
2,634
+12.0%
2,572
+13.0%
2,549
+11.4%
2,469
+7.4%
2,351
-3.2%
2,276
-11.0%
Debt
Debt due within a year
251
-61.6%
350
-48.5%
393
-27.2%
419
+8.3%
654
+4.8%
679
+49.2%
540
+74.2%
387
-28.1%
Long-term debt
1,683
+22.5%
1,688
+23.0%
1,699
+8.6%
1,734
+13.9%
1,374
-13.4%
1,372
-10.9%
1,565
-14.5%
1,522
+15.0%
Lease liabilities
154
-4.9%
151
-8.5%
160
-1.2%
165
+3.8%
162
-6.9%
165
-1.8%
162
-7.4%
159
-9.1%
Total debt
2,088
-4.7%
2,189
-1.2%
2,252
-0.7%
2,318
+12.1%
2,190
-8.1%
2,216
+2.5%
2,267
-2.1%
2,068
+1.5%
Net cash
-1,891
+3.8%
-1,812
+8.4%
-1,910
+1.8%
-1,714
+1.4%
-1,965
+0.2%
-1,979
-12.8%
-1,945
-11.4%
-1,738
-12.9%
Ratios
Current ratio
1.02x
1.03x
1.08x
1.05x
0.95x
0.93x
0.97x
0.96x
Debt to equity
0.85x
0.88x
0.85x
0.90x
0.86x
0.90x
0.96x
0.91x
Debt to EBITDA
1.45x
1.51x
1.51x
1.55x
1.44x
1.51x
1.59x
1.51x
Return on equity
25.34%
25.82%
26.92%
28.58%
29.50%
28.96%
29.22%
28.38%
Return on assets
7.39%
7.57%
8.37%
8.50%
8.89%
8.44%
8.47%
8.28%
Book value per share
—
—
—
34.43
—
—
—
29.29
How these figures are calculated

Quarterly columns are single-quarter amounts. When a 10-Q reports only a year-to-date total, as cash flow statements do, the quarter is that total minus the previous quarter's year-to-date total. The fourth quarter is the annual report's full year minus the first nine months. A column marked YTD is a year-to-date total, shown when the earlier report needed for the single quarter is missing. USD in millions, except ratios and per-share amounts. Cash and investments adds short-term and long-term marketable securities to cash. Debt due within a year is the borrowings that are not already in long-term debt. Total debt is those borrowings plus lease liabilities. Net cash is cash and investments minus total debt. Return on equity and return on assets divide the trailing twelve months of net income by the balance on that date. Debt to EBITDA uses the trailing twelve months of EBITDA. More on our methodology.

Company profile

Industry
Motor Vehicle Parts & Accessories (SIC 3714)
Listed as
ALV (NYSE)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Ogden, UT
SEC filer status
Large accelerated filer
SEC CIK
1034670
Former names
AUTOLIV INC (until Nov 2, 2026)

Other Motor Vehicle Parts & Accessories companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.